Sponsored By


Study on research: Minorities will participate, if asked.


Vitamin D may boost steroid responsiveness.

 
  
December 21, 2005
  
Welcome to ACAAI eNews — a bi-weekly aggregated news service from the American College of Allergy, Asthma & Immunology. To be removed from this distribution list, please see instructions at bottom.
 
Top Stories
   
Drugs & Devices
 
Distance Learning
      
Association News
   
Fellows-in-Training
   
Calendar
   
Archive
FIT Archive
 Members: update 
 e-mail address here
  
 Non-members:
 subscribe here

 

 ACAAI Home
  

Of these options, readers said the most appropriate source for funding clinical allergy-immunology subspecialty training was:
55% Medical schools and their associated hospitals
41% Federal government
5% State government
0% Managed care organizations

 

Distance Learning
2005 Board/Recertification Review Course:
DVDs, Audio CDs, MP3s
Link

ACAAI Tape Store
Complete Listing
Link

2004 ACAAI ANNUAL MEETING
Nov. 12-17, Boston
Link

From the 2003 ACAAI ANNUAL MEETING
Nov. 7-12, 2003, New Orleans

• Two Symposia Online
Link

• Plenary Sessions CD-ROM and DVD
Link

Patient-Centered Allergy Practice
Endorsed by ACAAI, Sponsored by Physicians Practice
Link

 
Calendar

JANUARY
The Management of Pediatric Allergy:
In Whose Hands? – from Bench to Bedside

In cooperation with ACAAI
Jan. 20-26, 2006
Milan, Italy
Tel: 39-02-34934404
Fax: 39-02-34934397
E-mail
Link

WSAAI 44th Annual Scientific Session
Western Society of Allergy, Asthma & Immunology (WSAAI)
Jan. 22-26, 2006
Lanai City, Hawaii
Tel: 623-266-9148
Fax: 628-266-7885
Link


ONGOING
World Allergy Organization Society Meetings

 Sponsored By

 
  
Top Stories
 
Study: Minorities willing to participate in research
Minorities participate in health research studies at the same rate as non-Hispanic whites when they are made aware of the study and meet the medical requirements, according to a report in PLoS Medicine, published by the Public Library of Science. The findings dispute the common belief that minorities are less willing to participate. Researchers at the National Institutes of Health identified and reviewed 20 studies that involved more than 70,000 patients over 20 years in a variety of types of research studies. Researchers found only small differences in the willingness of minorities to participate, but big differences in who was asked to participate. 

Vitamin D may help steroid-resistant patients
Vitamin D can improve responsiveness among patients who fail to respond to steroids, according to a study in the Journal of Clinical Investigation. The study’s results suggest that steroid treatment works, at least in part, by inducing the T-cells of the immune system to synthesize a secreted signaling molecule, IL-10, which inhibits the immune responses that cause allergic and asthmatic disease symptoms. T-cells from steroid-resistant patients did not produce IL-10 when cultured in vitro with the steroid, dexamethasone. But when vitamin D3 was added to the culture medium along with dexamethasone, this was reversed. Researchers gave patients with asthma, who were unresponsive to steroids, daily vitamin D3 supplements for seven days. Blood tests showed the patients' T-cells were more responsive to dexamethasone after they had taken the supplements.

FDA publishes food allergen labeling information
The Food and Drug Administration recently published information on its Web site for food manufacturers and consumers about the Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA), including a revision relating to the status of food allergen cross contact residues. The site includes questions and answers about food allergens in general and FALCPA specifically.   

Treating allergic rhinitis may be key to asthma control
Asthma management requires suitable treatment of allergic rhinitis, according to a study in Chest. Scientists at University of Sao Paulo School of Medicine in Brazil evaluated the effects of treatment with inhaled or topical nasal steroid beclomethasone dipropionate, given separately or in combination to 74 patients with mild-to-moderate asthma and allergic rhinitis. Patients in all treatment groups showed significant improvements in lung function, as well as in emergency department visits, nighttime waking due to asthma, and asthma-related work absences.   

U.S. customs agents confiscate counterfeit Tamiflu
Customs agents near San Francisco recently intercepted more than 50 shipments of counterfeit Tamiflu, the antiviral drug being stockpiled in case of a bird flu pandemic—the first such seizure in the United States, according to authorities. The counterfeits included none of Tamiflu's active ingredients. Initial tests indicate some vitamin C in the capsules, according to an FDA spokesperson. So far, intercepted shipments were bound only for individuals who placed Internet orders. None were bound for doctors or hospitals.  

  

A word from Dr. William Dolen, president
Let’s continue exploring options for the funding of allergy-immunology training programs. (Again, please send an e-mail to the ACAAI office with your feedback.) We pick up from the last issue at No. 4.

4. Private donations for a particular fellow. An allergy practice or an individual agrees to make a donation that covers expenses for a two-year allergy-immunology fellowship. The institution pays the fellow from the donation, at a salary equivalent to other institutional PGY-4 and PGY-5 salaries.

Advantages
The fellow is paid at the same rate as peers in other subspecialty fellowships.

Disadvantages
Some sort of agreement needs to ensure that the entire grant is received or otherwise guaranteed before the fellow signs an institutional training contract. Otherwise, if funds are withdrawn for some reason, the institution might be obligated to provide funding for the remainder of the fellowship.

When the donor is an allergy practice group, it is likely that the fellow would be contractually obligated to join that practice after training, and repay the cost of training over a period of time. If, in the course of training, the fellow decides not to join that practice, there could be issues. This potential event would have to be addressed prospectively in any agreement between the fellow and the allergy practice, as well as the fellow’s contract with the institution.

A fellow candidate with this kind of funding would have an unfair advantage over a more highly qualified candidate without funding.

5. Funding by the national allergy-immunology organizations. Both the ACAAI (Acorn grants, the ACAAI Foundation) and the AAAAI (ERT) have foundations and other sources of funds for fellowship training.

Advantages
Current availability

Disadvantages
Very limited funds are available for a large number of applicants.

6. The federal government. This was once the major source for subspecialty funding, which was reduced by the Balanced Budget Act. The JCAAI is actively designing an analysis of political options to restore funding for the cognitive outpatient-based specialties. The ACAAI and JCAAI hope to lobby Congress in 2006.

7. The last option is that the medical schools and their associated hospitals should fund allergy-immunology fellowship training. Most of those responding to the recent poll believe that this is the most appropriate source for funding. One individual wrote that having local control is preferable to federal control over how training might be conducted. Another person wrote that money earned by fellows working in the clinics and the hospital benefits the medical school and the hospital, and ought to go to cover the salaries of staff and fellows. Do any of the medical schools and/or hospitals have a practice plan in which clinical income covers salaries for staff and fellows? If so, please send a description to the ACAAI office.

Dr. William Dolen
ACAAI president

    
Plan to attend the ACAAI-HSACI meeting in Greece
The ACAAI and Hellenic Society of Allergy & Clinical Immunology (HSACI) are co-sponsoring a Joint Allergy Symposium, Allergy Update in Greece, Sept. 6-9, 2006, in beautiful Athens.

This international meeting brings together many of the finest researchers and clinicians to present cutting-edge lectures on the most important topics for the clinical practice of allergy and immunology.

Plan to join your colleagues in Athens, one of the most exciting cities in the world, the metropolis of wisdom, philosophy and inspiration. The modern Athens Ledra Marriott Hotel is the perfect venue for this meeting, with its spacious conference center and view of the Acropolis. 
    
Drugs and Devices
    
Xopenex HFA metered-dose inhaler now available
Sepracor Inc. recently announced that Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, a hydrofluoroalkane metered-dose inhaler, is now available by prescription. Xopenex HFA is a short-acting beta-agonist for the treatment or prevention of bronchospasm in patients four years and older with reversible obstructive airway disease. 
    
Association News
 

Take advantage of $100 ACAAI member discount for iHealth Services
As an ACAAI member, you have access to a practice Web site that has recently been upgraded with tools that can help you increase your practice revenue, improve patient satisfaction, reduce your liability and improve your practice marketing.

Beginning in 2006, ACAAI members will be able to continue utilizing iHealth Services for just $17 per month—a $100 annual savings because the College is a founding member of Medem. If you have 300 of your patients sign up for an iHealthRecord via your practice Web site in 2006 or perform at least one charged-for Online Consultation on average per week during the 2006 calendar year, your 2006 fees will be credited to your 2007 subscription.

By using Medem, Inc.’s iHealth Services you can create a practice Web site, have your patients complete a secure online personal health record—the iHealthRecord—communicate with them through Online Consultation and Secure Messaging tools to provide your patients with health education and adherence programs, including asthma and other allergic diseases. If you have any questions contact Medem’s Member Services at info@medem.com or 877-926-3336.

The AAAAI/ACAAI Certification/Maintenance
of Certification Board Review Course to be April 6-9
The 2006 AAAAI/ACAAI Certification/Maintenance of Certification Board Review Course is April 6-9 at the Westin Michigan Avenue Hotel in Chicago. The intensive literature review course will give you the winning edge whether you are preparing for the ABAI exam, ABAI recertification, or simply strengthening your skills. The program and registration are online.

Developed by outstanding faculty members, this three and one-half day course covers the major concepts included in the written exam and includes a comprehensive syllabus. Participants will hear summaries and review questions on subjects of interest to allergist/immunologists. At the conclusion of the meeting, participants should be able to identify, evaluate and manage the current problems and issues in allergy/immunology in preparation for the ABAI examination.

ABAI Certification, Recertification Exams Oct. 9-13, 2006
Due to conflicts at the computer-based testing centers, the ABAI will administer both the Certification and Recertification Examinations the week of October 9-13, 2006. For more information, please contact the ABAI:

American Board of Allergy and Immunology
510 Walnut Street, Suite 1701
Philadelphia, PA 19106-3699
Tel 215-592-9466; Fax 215-592-9411
http://www.abai.org
abai@abai.org

Allergy Practice Tip: Get Smiles
Advice from The Patient-Centered Allergy Practice

Friendly employees beget happy patients. Consider hiring front-end staff based on personality as much as experience. And hard-working quick learners with good customer service skills are a must. For more advice, visit www.PatientCenteredAllergyPractice.com.

These tips are drawn The Patient-Centered Allergy Practice, a CME Series in Practice Management, supported through an educational grant from sanofi-aventis Group and endorsed by the American College of Allergy, Asthma & Immunology.

 
Fellows-in-Training
 

Immunology Review Corner
Welcome to the Board Review Corner, prepared by Dr. Karla R. Davis, senior representative of ACAAI’s fellows-in-training (FITs) to the Board of Regents. The Board Review Corner is your chance to test your Board preparedness.

To refer to a previous Board Review Corner, click the “Archive” link in the left column.

Immunology Review Corner: Chapter 59, Part II of the 6th edition of Middleton’s Allergy Principles and Practice, edited by N. Franklin Adkinson, et al. Review questions were written by Drs. Thao Tran and Karla Davis. 


Copyright © 2005 American College of Allergy, Asthma & Immunology. All rights reserved.

E-newsletter services provided by the medical editors at Ascend Media, LLC.

Do you have news, responses or opinions to share with us? Please e-mail the association office at enews@acaai.org
  
THIS E-MAIL WAS SENT FROM A “SEND-ONLY” MAILBOX. Please DO NOT REPLY to this e-mail.
ACAAI eNews is sent as a membership benefit of the American College of Allergy, Asthma & Immunology. If you would prefer not to receive future issues and want to remove your name from our mailing list, please -click here-